- Original research
- Open Access
Correlation between apoptosis and left ventricular remodeling in subacute phase of myocardial ischemia and reperfusion
© Wakabayashi et al. 2015
Received: 7 September 2015
Accepted: 1 December 2015
Published: 10 December 2015
To investigate whether an apoptotic process demonstrated by 99mTc-annexin-V (99mTc-AV) uptake correlates with left ventricular remodeling (LVR) after myocardial infarction, we assessed 99mTc-AV uptake in rat model of myocardial ischemia and reperfusion.
The left coronary artery (LCA) of 15 rats was occluded for 20 to 30 min, followed by reperfusion. After 2 weeks, 99mTc-AV was injected, and then 1 h later, 201Tl was injected after reocclusion of the LCA. Dual-tracer autoradiography was performed to assess 99mTc-AV uptake and the area at risk (AAR) by 201Tl defect. 99mTc-AV uptake ratio was calculated by dividing the count density of the AAR by that of the normally perfused area. In short-axis LV slices, LV cavity dilation index (DI) was calculated by dividing the area of LV cavity by that of the whole LV area. LV wall-thinning ratio (WTR) was calculated by dividing the LV wall thickness in the AAR by that of the normally perfused area.
Significant 99mTc-AV uptake in the AAR was observed in 10 rats. DI was significantly higher in rats with positive 99mTc-AV uptake than in rats without uptake. WTR was smaller in rats with positive 99mTc-AV uptake than in rats without uptake.
The data suggest 99mTc-AV uptake in injured myocardium might correlate with LVR at 2 weeks after myocardial ischemia and reperfusion.
Cardiomyocyte death by apoptosis during ischemia-reperfusion and myocardial infarction (MI) is associated with the progression of left ventricular (LV) dysfunction and remodeling [1–3]. The progressive loss of cardiomyocytes after acute MI (AMI) and ischemia-reperfusion may play a key role in the pathogenesis of heart failure.
Apoptosis is triggered through two main pathways: (1) the intrinsic pathway involves mitochondria and cytoplasmic reticulum, and (2) the extrinsic pathway utilizes cell surface receptor. Cellular stresses such as infarction and ischemia-reperfusion induce apoptosis through the intrinsic pathway [4–7]. These stimuli lead to the release of several factors into cytosol including cytochrome c, which activates the initiator caspase-9 via the apoptosome followed by the activation of effector caspases. The activation of downstream caspases leads to the cleavage of numerous structural and regulatory cellular proteins, thereby producing the apoptotic phenotype characterized by cell shrinkage, chromatin condensation, nucleus fragmentation, and externalization of phosphatidylserine (PS) on the outside of the cell membrane that serves as a signal for phagocytes. Annexin-V, a member of a phospholipid binding family of proteins, binds to PS-containing sites on the cell surface and has been suggested to be an early marker of apoptosis. Then, radiolabeled annexin-V has been used for the detection of apoptosis as a noninvasive imaging tool .
The process of myocardial tissue repair and healing after AMI is considered to consist of four phases based on the pathologic findings: cardiomyocyte death, acute inflammation, formation of granulation tissue, and scar formation . After 2 weeks of MI, granulation tissue formation in the ischemic area is ongoing. The granulation tissue is still rich in inflammatory cells like lymphocytes and macrophages for helping to clear the cellular debris. At this point, the prolonged 99mTc-annexin-V uptake by cardiomyocyte might correlate with a variety of tissue repair and healing.
Our previous studies showed that 99mTc-annexin-V binding commenced at 0.5 h after ischemia-reperfusion in the mid-myocardium within the area at risk (AAR) and expanded to the subendocardial and subepicardial layers at 6 h after ischemia-reperfusion in rat models [10, 11]. The 99mTc-annexin-V binding diminished gradually over 3 days and continued till 2 weeks after reperfusion. However, we could not assess the relation between 99mTc-annexin-V uptake and LV remodeling, because we only had investigated five rats with 20 min of ischemia at 2 weeks after reperfusion.
Therefore, we investigated whether apoptosis or cell death demonstrated by 99mTc-annexin-V uptake correlated with LV remodeling in rat models of myocardial ischemia-reperfusion at 2 weeks after reperfusion.
Animal model of acute ischemia and reperfusion
Male Wistar rats 8–9 weeks old were anesthetized with intraperitoneal administration of pentobarbital, 40 mg/kg, and were ventilated mechanically with room air. After left thoracotomy and exposure of the heart, a 7-0 polypropylene suture on a small curved needle was passed through the myocardium beneath the proximal portion of the left coronary artery (LCA), and both ends of the suture were passed through a small vinyl tube to make a snare. The suture material was pulled tightly against the vinyl tube to occlude the LCA. The occlusion time was 20 (n = 9) or 30 min (n = 6) for making differences in severity of ischemia [12, 13]. Myocardial ischemia was confirmed by ST-segment elevation on electrocardiography and by regional cyanosis of the myocardial surface. The snare was left loose on the surface of the heart for reocclusion of the LCA just before sacrificing the animals to identify the AAR.
At 2 weeks after reperfusion, 99mTc-annexin-V (80–150 MBq) was injected via tail vein under anesthesia. After 1 h of the tracer injection, 0.74 MBq of 201Tl was injected just after reocclusion of the proximal portion of the LCA for delineation of the AAR. One minute later, the rat was euthanized by exsanguination in accordance with institutional guidelines and the heart was removed for analysis. The heart was rinsed in saline, embedded in methylcellulose, and cooled in a freezer. Serial short-axis heart sections of 20 μm thick were obtained using a cryostat to create a series of rings for autoradiography.
Dual-tracer autoradiography of the left ventricular short-axis slices was performed to assess 99mTc-annexin-V uptake and AAR (201Tl uptake). The first exposure on an imaging plate (BAS-MS; Fuji Film) was performed for 15–20 min to visualize 99mTc-annexin-V distribution 1–2 h after sacrifice. Three days later (12 half-lives of 99mTc), the second exposure was made for 24 h to image the AAR expressed by 201Tl distribution.
All animal experimental protocols were approved by the Institute for Animal Studies of Kanazawa University.
Radiolabeling of annexin-V
Mutant annexin-V (annexin V-117 mutant, a form of recombinant human annexin engineered to include a binding site for technetium) was prepared through expression in Escherichia coli. This material retains PS-binding activity equivalent to that of native annexin-V. A specific activity of 3.7–7.4 MBq (100–200 μCi)/μg of protein with a radiopurity of more than 90 % was achieved using a radiolabeling protocol .
Indexes of LV remodeling
In each three short-axis LV slices, LV cavity dilation index (DI) was calculated by dividing the area of LV cavity by that of the whole LV area. Then the average of DIs from three slices was considered as a representative value. LV wall-thinning ratio (WTR) was calculated by dividing the LV wall thickness in the AAR by that in the normally perfused LV area. Each area’s wall thickness was calculated as an average of three radial lines those equally divided the area into four. Then the average of WTRs from three slices was calculated as a representative value (Fig. 1).
Histopathologic examinations with light microscopy
Hematoxylin- and eosin-stained (HE) slices adjacent to the slices used for autoradiography were examined histopathologically by light microscopy (×400).
In situ detection of nuclear DNA fragmentation
Rat heart tissues were examined histopathologically for terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) immunoreactivity to detect the presence of DNA fragmentation.
For all statistical analysis, we used a statistical software package (JMP® SAS Institute Inc., Cary, NC, USA). Contingency table analysis was used for the relations between ischemic time and 99mTc-annexin-V uptake. All results were expressed as mean value ± standard deviation (SD). Group comparisons were performed using analysis of variance. The Pearson product-moment correlation coefficient measures the strength of the linear relationship. A value of P < 0.05 was considered statistically significant.
The ratio of AAR to the whole LV area was not significantly different between 20 and 30 min of ischemia (mean value ± SD; 0.41 ± 0.05 vs. 0.53 ± 0.07, P = 0.2).
The present study confirmed that 99mTc-annexin-V uptake was observed at 2 weeks after LCA occlusion and reperfusion in rats with a dilated LV cavity and thinned wall using autoradiography. Since 99mTc-annexin-V uptake might reflect ongoing cell death of cardiomyocytes, the detection of apoptosis can be used as a diagnostic tool for predicting loss of cardiomyocytes in the vulnerable myocardial areas during the postinfarction recovery period.
99mTc-annexin-V uptake seems to depend on the severity of ischemia-reperfusion injury in the rat model. Previous investigations demonstrated that apoptosis was observed at AAR after short-time ischemia and that apoptosis was involved extensively in border zone after long-time ischemia . In this study, the size ratio of AAR to whole LV was not different between LCA occlusion time, but 99mTc-annexin-V uptake in the AAR was significantly more observed in 30 min in the LCA occlusion model. Our results agreed with the previous findings that myocardial apoptosis appeared in ischemia-reperfusion area and that apoptosis was useful to evaluate ischemia-reperfusion damage.
Loss of myocardium caused by apoptosis in the acute phase of MI contributed to progressive myocardial dysfunction in human clinical studies. Human clinical studies demonstrated that increased uptake of 99mTc-annexin-V was present in the infarct area in patients with AMI after percutaneous coronary intervention [16, 17]. In these studies, timing of monitoring apoptosis was based on the acute phase of MI, because apoptosis of myocardium was observed most strongly in the acute phase after ischemic damage.
Then, how long has apoptosis been observed in rat model? Palojoki et al.  showed that cardiomyocyte apoptosis occurred continuously over an extended period of time in the viable border zones of infarct scars in a rat model of permanent ligation. TUNEL-positive cardiomyocytes were numerous at 1 day after LCA ligation in both the viable border zones and the central infarct areas (average value 4.39 and 1.44 %). At later time points, scattered TUNEL-positive cardiomyocytes were observed in both the border zones adjacent to infarct scars and the remote myocardium (average value 0.34 and 0.09 % at 4 weeks, 0.10 and 0.04 % at 12 weeks, respectively).
Cardiomyocyte apoptosis occurs in advanced heart failure after the acute phase of MI. Olivetti et al.  demonstrated the existence of cardiomyocyte apoptosis morphologically and biochemically in patients who underwent cardiac transplantation for intractable congestive heart failure. Abbate et al.  examined an apoptotic rate (AR), the ratio of the number of cardiomyocytes co-expressing positive TUNEL and caspase-3 on nucleated cells per field, in both the infarct and the remote area in patients dying ≥10 days after AMI. The higher AR in the infarct area correlated with relative LV cavity dilation strongly but AR in the remote area did not. Apoptotic rate at the site of the infarction was increased nearly fourfold in patients with symptomatic heart failure at the time of initial hospitalization for AMI or subsequently before death versus remaining patients (median value 26.2 vs. 6.4 %). Our results consisted with their findings in that the positive 99mTc-AV uptake in the AAR correlated with LV cavity dilation and thinned wall. Interestingly, the two rats demonstrated significant uptake expanded over the border zone between ischemic and normally perfused area after ischemia and reperfusion. Although apoptotic cardiomyocytes in remote non-infarcted areas contribute to the LV remodeling in rodent models of permanent ligation [18, 21, 22], such an apoptotic process over border zones in subacute phase had not been reported. In this respect, further study would be warranted to determine the significance of 99mTc-AV uptake in the normally perfused area.
First, although 99mTc-annexin-V uptake should depend on the externalized PS on apoptotic cells, the uptake also might reflect necrotic cells. There might be little binding of annexin-V to necrotic cells because myocytes have a significant intracellular content of (unlabeled) annexin-V. In rat cardiomyocytes, annexin-V is found predominantly on the sarcolemma and intercalated disks within the myocytes , and its content is extremely high (around 130 μg/g of wet weight)  and far greater than the concentration of the radiolabeled annexin-V, when 30 μg of labeled annexin-V are injected per rat (about 250 g of body weight) in our experiment. Based on the relative concentration gradient, exogenous radiolabeled annexin-V will not easily enter the intracellular environment and bind to PS competitively. Our study also demonstrated that the distribution of annexin-V was consistent with the area of TUNEL staining. Therefore, we believe that 99mTc-annexin-V reflects apoptosis considerably if not completely. Second, 99mTc-annexin-V uptake and morphological changes were evaluated only by autoradiography, because 99mTc-annexin-V binding at 2 weeks was not expected to be high based on previous studies . Although the uptake value was obtained semi-quantitatively by autoradiography, other imaging modalities including high-resolution animal SPECT, ultrasonography, and MRI may provide more accurate anatomical and functional information for monitoring serial change of 99mTc-annexin-V uptake simultaneously.
99mTc-annexin-V uptake in injured myocardium correlated with LV remodeling at 2 weeks after myocardial ischemia-reperfusion. Ischemia-driven apoptosis or cell death demonstrated by 99mTc-annexin-V uptake in the subacute phase might be a possible marker of LV remodeling.
The costs of publication of this article were defrayed in part by the payment of page charges. This work has been supported by Grants-in-Aid for scientific research (No. 26860984 and 26461847) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 1994;94:1621–8.PubMed CentralView ArticlePubMedGoogle Scholar
- Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 1996;74:86–107.PubMedGoogle Scholar
- Garg S, Narula J, Chandrashekhar Y. Apoptosis and heart failure: clinical relevance and therapeutic target. J Mol Cell Cardiol. 2005;38:73–9.View ArticlePubMedGoogle Scholar
- Foo RS, Mani K, Kitsis RN. Death begets failure in the heart. J Clin Invest. 2005;115:565–71.PubMed CentralView ArticlePubMedGoogle Scholar
- Hori M, Nishida K. Oxidative stress and left ventricular remodeling after myocardial infarction. Cardiovasc Res. 2009;81:457–64.View ArticlePubMedGoogle Scholar
- Taki J, Wakabayashi H, Inaki A, Matsunari S, Kinuya S. Apoptosis imaging in diseased myocardium. In: Gholamrezanezhad A, editor. The book 12 Chapters on Nuclear Medicine. Rijeka: InTech; 2011. p. 251–64.Google Scholar
- Dorn 2nd GW. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodeling. Cardiovasc Res. 2009;81:465–73.PubMed CentralView ArticlePubMedGoogle Scholar
- Korngold EC, Jaffer FA, Weissleder R, Sosnovik DE. Noninvasive imaging of apoptosis in cardiovascular disease. Heart Fail Rev. 2008;13:163–73.PubMed CentralView ArticlePubMedGoogle Scholar
- Blankesteijn WM, Creemers E, Lutgens E, Cleutjens JP, Daemen MJ, Smits JF. Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol Scand. 2001;173:75–82.View ArticlePubMedGoogle Scholar
- Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, et al. Detection of Cardiomyocyte Death in a Rat Model of Ischemia and Reperfusion Using 99mTc-Labeled Annexin V. J Nucl Med. 2004;45:1536–41.PubMedGoogle Scholar
- Taki J, Higuchi T, Kawashima A, Tait JF, Muramori A, Matsunari I, et al. (99m)Tc-Annexin-V uptake in a rat model of variable ischemic severity and reperfusion time. Circ J. 2007;71:1141–6.View ArticlePubMedGoogle Scholar
- Taki J, Inaki A, Wakabayashi H, Imanaka-Yoshida K, Ogawa K, Hiroe M, et al. Dynamic expression of tenascin-C after myocardial ischemia and reperfusion: assessment by 125I-anti-tenascin-C antibody imaging. J Nucl Med. 2010;51:1116–22.View ArticlePubMedGoogle Scholar
- Arheden H, Saeed M, Higgins CB, Gao DW, Ursell PC, Bremerich J, et al. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume ofcontrast material with echo-planar MR imaging. Radiology. 2000;215:520–8.View ArticlePubMedGoogle Scholar
- Tait JF, Brown DS, Gibson DF, Blankenberg FG, Strauss HW. Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc. Bioconjug Chem. 2000;11:918–25.View ArticlePubMedGoogle Scholar
- Krijnen PA, Nijmeijer R, Meijer CJ, Visser CA, Hack CE, Niessen HW. J Apoptosis in myocardial ischaemia and infarction. Clin Pathol. 2002;55:801–11.View ArticleGoogle Scholar
- Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000;356:209–12.View ArticlePubMedGoogle Scholar
- Thimister PW, Hofstra L, Liem IH, Boersma HH, Kemerink G, Reutelingsperger CP, et al. In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med. 2003;44:391–6.PubMedGoogle Scholar
- Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki LM, et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol. 2001;280:H2726–31.PubMedGoogle Scholar
- Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the falling human heart. N Engl J Med. 1997;336:1131–41.View ArticlePubMedGoogle Scholar
- Abbate A, Biondi-Zoccai GG, Bussani R, Dobrina A, Camilot D, Feroce F, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol. 2003;41:753–60.View ArticlePubMedGoogle Scholar
- Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101:2981–8.View ArticlePubMedGoogle Scholar
- Qin F, Liang MC, Liang CS. Progressive left ventricular remodeling, myocyte apoptosis, and protein signaling cascades after myocardial infarction in rabbits. Biochim Biophys Acta. 2005;1740:499–513.Google Scholar
- Luckcuck T, Trotter PJ, Walker JH. Localization of annexin V in the adult and neonatal heart. Biochem Biophys Res Commun. 1997;238:622–8.View ArticlePubMedGoogle Scholar
- Matsuda R, Kaneko N, Kikuchi M, Chiwaki F, Toda M, Ieiri T, et al. Clinical significance of measurement of plasma annexin V concentration of patients in the emergency room. Resuscitation. 2003;57:171–7.View ArticlePubMedGoogle Scholar